Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

So-Called Rare Diseases Are Too Common to Ignore

Posted on June 19th, 2017 by in Pharma R&D

It’s time to re-think our attitude towards rare diseases. Even though relatively few people suffer from any given rare disease, there are so many of these maladies that it’s a surprisingly large swath of the population that is actually victimized by them. Continue reading “So-Called Rare Diseases Are Too Common to Ignore” »

Targeting Rare Diseases

Posted on March 20th, 2017 by in Pharma R&D

What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »

How Bioinformatics is Boosting Precision Medicine

Posted on January 9th, 2017 by in Pharma R&D

Although the pharmaceutical industry has invested a great deal in data-producing technologies (e.g. next-generation and single cell sequencing), it has been slower to invest in the data management and analytics technologies Continue reading “How Bioinformatics is Boosting Precision Medicine” »

“Own Goals”: the price is higher than you might think

Posted on December 28th, 2016 by in Pharma R&D

As a professional, giving points away, or being involved in an “own goal,” must be quite an emotional roller coaster. However, in professional sports, the individual needs to get on with the game, put the error behind them, and move on to deal with the immediate situation. Continue reading ““Own Goals”: the price is higher than you might think” »

  1. 1
  2. 2
  3. 3